• Mashup Score: 1
    Home - 1 year(s) ago

    STS/ACC TVT Registry About the Registry Created by a collaboration between the Society for Thoracic Surgeons (STS) and the American College of Cardiology(ACC), the STS/ACC TVT RegistryTM monitors patient safety and real-world outcomes related to transcatheter valve replacement and repair procedures – emerging treatments for valve disease patients. Employing state-of-the-art heart valve…

    Tweet Tweets with this article
    • This year marked a major milestone: #TVTRegistry turned a decade old! 🎉🎉 We celebrated 10 years of data collection and #QI for #TAVR & #TEER procedures. https://t.co/vpljT33OnC https://t.co/nUfsV8r7qw

  • Mashup Score: 0

    BOSTON — In a large registry analysis, transcatheter edge-to-edge mitral valve repair had a high rate of device success in patients with severe mitral regurgitation and cardiogenic shock.In addition, compared with device failure, device success with the mitral valve repair system (MitraClip, Abbott) was associated with reduced risk for all-cause mortality at 1 year.

    Tweet Tweets with this article
    • According to a #TVTRegistry analysis at #TCT2022 & published in #JACC, TEER had a high success rate for devices in patients w/ severe #vhdMR & cardiogenic shock. #ACCIC Member Dr. Neal Kleiman shares his perspective on the study in @CardiologyToday: https://t.co/9LPgwvfOn3

  • Mashup Score: 0

    BOSTON — In a large registry analysis, transcatheter edge-to-edge mitral valve repair had a high rate of device success in patients with severe mitral regurgitation and cardiogenic shock.In addition, compared with device failure, device success with the mitral valve repair system (MitraClip, Abbott) was associated with reduced risk for all-cause mortality at 1 year.

    Tweet Tweets with this article
    • In a #TVTRegistry analysis presented at #TCT2022 & published in #JACC, transcatheter edge-to-edge mitral valve repair had a high device success rate in patients with severe #vhdMR & cardiogenic shock. Read more in @CardiologyToday: https://t.co/9LPgwvfOn3 #cvSurg @ScottBuzby